top of page
NEWS & INSIGHTS
Dive into the Biopharma Space
Stay up-to-date on major biopharma news, deeper dives into specific companies and biopharma themes, and how it all relates to biopharma partners.
FEATURED POST
🎯 How to Find and Export Contacts in BiopharmIQ: A Step-by-Step Guide for Sales & Marketing Teams
BiopharmIQ is designed to empower sales and marketing professionals in the life sciences industry with targeted lists of companies and...
BiopharmIQ
Gene Editing Companies Landscape
Gene editing has emerged as one of the most transformative technologies in biotech and pharma, with applications spanning therapeutics,...
Apr 3
🎯 How to Find and Export Contacts in BiopharmIQ: A Step-by-Step Guide for Sales & Marketing Teams
BiopharmIQ is designed to empower sales and marketing professionals in the life sciences industry with targeted lists of companies and...
Apr 2
7 FDA Approval Decisions Coming This Quarter
7 FDA approval decisions are expected by March 2025 with insights from biopharmIQs platform. Learn about them and our new Team Plan.
Feb 27
Annual 2024 Funding Report: Early & Late Stage Bio/Pharma Funding Over $1M
The global biotech and pharmaceutical landscape in 2024 continued to attract significant investment, with our BiopharmIQ system capturing...
Feb 19
2024’s New & Emerging Biologic Companies: The Rise of Antibody Therapeutics & Next-Gen Biologics
The latest wave of new and emerging biologic companies in 2024 highlights a continued diversity of technology areas with a strong focus...
Feb 11
December 2024 Early & Late-Stage >$1M Funded Bio/Pharma Companies
Bio/pharma continued to attract investments in December 2024 to support the discovery and development of new bio/pharma therapeutics. In...
Jan 31
2024 Breakthrough: 9 New Cell and Gene Therapies Approvals
We've come a long way since the first monoclonal antibody, Muromonab-CD3 (OKT3) was approved in 1986. It took more than 30 years after...
Jan 23
Annual Report of New/Newly Emerging Bio/Pharma Companies in 2024
This annual report analyzes our biopharmIQ data on new/emerging bio/pharma companies for 2024 to provide insights into the geographic and...
Jan 15
4 Companies with FDA Approval Decisions Expected Before the End of January
We used our  biopharmIQ online platform  to identify upcoming FDA approval (PDUFA) dates for biopharma companies through the end of...
Jan 9
New/Newly Emerging Bio/Pharma Companies (December 2024)
We identified two (2) new or newly emerging biotech companies for December 2024. To find these new/emerging bio/pharma companies, every...
Jan 6
November 2024 Early & Late-Stage >$1M Funded Biotech Companies
We analyzed biotech funding data on our online biopharmIQ platform to identify companies who had early-stage (Angel/Pre-Seed, Seed,...
Dec 30, 2024
New/Newly Emerging Bio/Pharma Companies (November 2024)
We’ve identified seven (7) new or newly emerging bio/pharma companies for November 2024. To detect these new/emerging bio/pharma ...
Dec 16, 2024
5 Companies with FDA Approval Decisions Expected Before the End of December
We used our  biopharmIQ online platform  to identify upcoming FDA approval (PDUFA) dates for small and mid-sized biopharma companies...
Dec 5, 2024
AI in Bio/Pharma Technology Development
There is a lot that has been published about the possible impact of AI on healthcare and the development of new therapeutics. In fact,...
Nov 26, 2024
November PDUFA Update: 4 Approvals and 1 AdComm
November has 4 FDA approvals so far. Most recently, the FDA approved Jazz Pharmaceuticals & Zymeworks’ Ziihera (zanidatamab) and Autolus’...
Nov 21, 2024
2024 Q1-Q3 Late Stage >$1M Funding: Series B and Beyond
We analyzed biotech funding data on our online biopharmIQ platform  to identify companies who had late-stage* biotech funding events...
Nov 11, 2024
Set up an alert (newly funded or newly emerged biopharma company, new clinical trial, lots more) today and increase your sales
At biopharmIQ, we're excited to introduce our new alerts feature , which notifies you via email at times when a significant event occurs...
Oct 31, 2024
Prospect Recently Funded Companies in 5 Steps
A valuable signal (i.e. hot lead) for vendors is when a potential customer closes a funding round. We identify these funding events and...
Oct 24, 2024
6 companies with FDA approval decisions expected before the end of November
We used our biopharmIQ online platform to identify upcoming FDA approval (PDUFA) dates for small and mid-sized biopharma companies...
Oct 24, 2024
Quarter by Quarter New/Emerging Cell & Gene Therapy Companies in 2024
New cell & gene therapy (CGT) companies continue to emerge in 2024. To detect these new/emerging CGT companies, every workday, our team...
Oct 14, 2024
Please fill out the following information along with your message.
bottom of page